Showing results (31-40 of 117) with videos related to
Sort By:
Pageof 12
Journal of Interventional Cardiology|August 3, 2006
Does proximal location of culprit lesion confer worse prognosis in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction?Kishore J Harjai, Rajendra H Mehta, Gregg W Stone, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 14, 2014
Sex-based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: three year results from the HORIZONS-AMI trialJennifer Yu, Roxana Mehran, Liliana Grinfeld, et al.The American Journal of Cardiology|October 1, 2003
Variation in hospital length of stay in patients with acute myocardial infarction undergoing primary angioplasty and the need to change the diagnostic-related group systemBeth A Bartholomew, Kishore J Harjai, Cindy L Grines, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 30, 2013
Impact of advanced age on the safety and effectiveness of paclitaxel-eluting stent implantation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: The HORIZONS-AMI trialDariusz Dudek, Roxana Mehran, Artur Dziewierz, et al.American Heart Journal|June 3, 2008
Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial)George Dangas, Gregg W Stone, Mitchell D Weinberg, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 28, 2013
Impact of bifurcation target lesion on angiographic, electrocardiographic, and clinical outcomes of patients undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial)Dariusz Dudek, Roxana Mehran, Artur Dziewierz, et al.The American Journal of Cardiology|March 19, 2013
Frequency, mechanisms, and implications of late peri-stent contrast staining: analysis (from the HORIZONS-AMI Trial)Tadayuki Yakushiji, Shinji Inaba, Akiko Maehara, et al.Coronary Artery Disease|April 29, 2015
Morphological changes and clinical impact of unstable plaques within untreated segments of acute myocardial infarction patients during a 3-year follow-up: an analysis from the HORIZONS-AMI trialCristiano F Souza, Hiroshi Doi, Gary S Mintz, et al.Journal of the American College of Cardiology|October 3, 2009
Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trialGeorge Dangas, Roxana Mehran, Giulio Guagliumi, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 20, 2008
Outcomes with drug-eluting stents versus bare metal stents in acute ST-elevation myocardial infarction: results from the Strategic Transcatheter Evaluation of New Therapies (STENT) GroupBruce R Brodie, Thomas Stuckey, William Downey, et al.Pageof 12